Stay updated on Efficacy Safety Rituximab + Omalizumab Clinical Trial

Sign up to get notified when there's something new on the Efficacy Safety Rituximab + Omalizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Efficacy Safety Rituximab + Omalizumab Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Withdrawn status is displayed for the study, and several regulatory disclosures (FDA-regulated product indicators, IPD sharing plans) have been removed. Related details such as PI/IRB status and regulatory notes are no longer visible.
    Difference
    17%
    Check dated 2026-01-21T02:47:34.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The only change is a footer revision label updated to Revision: v3.3.4 (replacing v3.3.3); this is a minor, technical update and does not affect study details, data, or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:40:53.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Locations now include California under Locations. The California Locations entry and HHS Vulnerability Disclosure link were removed, and the page revision updated to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T09:22:48.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Revision: v3.3.2 replacing v3.3.1. No visible changes to study content are indicated.
    Difference
    0.1%
    Check dated 2025-12-01T16:59:11.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Revision: v3.3.1 replaces the previous v3.2.0 on the page. No changes to study details, eligibility, or outcome measures are evident.
    Difference
    0.1%
    Check dated 2025-11-24T14:32:53.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The site removed the government funding status notice that used to appear on this page, and the core study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T06:48:58.000Z thumbnail image

Stay in the know with updates to Efficacy Safety Rituximab + Omalizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Efficacy Safety Rituximab + Omalizumab Clinical Trial page.